Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemia.
Ingegerd ÖfverholmVasilios ZachariadisFulya TaylanYanara Marincevic-ZunigaAnh Nhi TranLeonie SaftDaniel NilssonAnn-Christine SyvänenGudmar LönnerholmArja Harila-SaariMagnus NordenskjöldMats HeymanAnn NordgrenJessica NordlundGisela BarbanyPublished in: Leukemia & lymphoma (2019)
Intrachromosomal amplification of chromosome 21 (iAMP21) is a cytogenetic subtype associated with relapse and poor prognosis in pediatric B-cell precursor acute lymphoblastic leukemia (BCP ALL). The biology behind the high relapse risk is unknown and the aim of this study was to further characterize the genomic and transcriptional landscape of iAMP21. Using DNA arrays and sequencing, we could identify rearrangements and aberrations characteristic for iAMP21. RNA sequencing revealed that only half of the genes in the minimal region of amplification (20/45) were differentially expressed in iAMP21. Among them were the top overexpressed genes (p < 0.001) in iAMP21 vs. BCP ALL without iAMP21 and three candidate genes could be identified, the tyrosine kinase gene DYRK1A and chromatin remodeling genes CHAF1B and SON. While overexpression of DYRK1A and CHAF1B is associated with poor prognosis in malignant diseases including myeloid leukemia, this is the first study to show significant correlation with iAMP21-positive ALL.
Keyphrases
- poor prognosis
- tyrosine kinase
- genome wide
- acute lymphoblastic leukemia
- long non coding rna
- genome wide identification
- transcription factor
- copy number
- epidermal growth factor receptor
- single cell
- gene expression
- dna methylation
- bioinformatics analysis
- acute myeloid leukemia
- cell proliferation
- genome wide analysis
- dna damage
- nucleic acid
- bone marrow
- allogeneic hematopoietic stem cell transplantation
- dendritic cells
- immune response
- free survival
- high density
- circulating tumor
- single molecule
- circulating tumor cells
- heat shock protein